Fusion biopsy Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031

The global Fusion biopsy market is anticipated to grow at a CAGR of 8.4% during the forecast period (2024-2031). The global Fusion biopsy market is anticipated to grow at a significant rate owing to several factors which includes, improved diagnostic accuracy, increasing focus on early detection and personalized treatment and rising prevalence of prostate cancer. Prostate cancer is the most common cancer among men (after skin cancer), but it can often be treated successfully. According to world cancer research fund international, there were an estimated 18.1 million cancer cases around the world in 2020. Of these, 9.3 million cases were in men and 8.8 million in women. And Prostate cancer is the 2nd most commonly occurring cancer in men and the 4th most common cancer overall. There were more than 1.4 million new cases of prostate cancer in 2020.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/fusion-biopsy-market

In April 2023, UC San Diego Health is the first health system in San Diego County to offer a new minimally invasive prostate biopsy procedure that reduces the risk of infection, improves imaging for accuracy and may increase cancer detection in a clinic setting. Called a transperineal biopsy, the procedure is combined with 3D MRI fusion guided technology to highlight prostate cancer. It is the latest urological cancer diagnostic tool to be added to an extensive list of innovative resources used for diagnosing cancer at UC San Diego Health. Traditionally, a transrectal biopsy was the standard procedure to test for prostate cancer if a prostate-specific antigen blood test was elevated and/or a digital rectal exam was flagged.

In January 2023, aiming to revolutionise prostate cancer detection and treatment, Apollo Hospital Seshadripuram has introduced a novel technology, MRI Fusion TRUS guided Trans-Perineal Targe¬ted Biopsy, that enhances the accuracy of cancer detection by 95 to 97%. "In this procedure, one has to undergo multi-parametric MRI and contouring of the lesions which are suspected to be cance¬rous, and prostate size is marked via a special software pack.

Global Fusion biopsy Market Report Segment

By Biopsy Route

Transrectal
Transperineal

By End-use

Hospitals
Diagnostic Centers
Ambulatory Care Centers

A full report of Fusion biopsy Market available @ https://www.omrglobal.com/industry-reports/fusion-biopsy-market

Company Profiles

Eigen Health
Focal Healthcare
GeoScan Medical
Hitachi Ltd.
innoMedicus Ltd
KOELIS
MEDCOM Sp. z o. o

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.